Anton Terwisscha van Scheltinga

Statistics

Publications

Citations

226

H-Index

Active since

2017

Affiliations

Leiden University Medical Center(Current)

Leiden University

Centre for Human Drug Research

Anton Terwisscha van Scheltinga is an author at Leiden University Medical Center specializing in immunotherapy, cancer vaccine delivery systems, and cancer immunotherapy.

Publications per year

2017–2020

Publications

Hollow microneedle-mediated micro-injections of a liposomal HPV E743–63 synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responses

Koen van der Maaden, Jeroen Heuts, Marcel Camps et al. · Journal of Controlled Release · 2017 · 111 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +17

Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides

Jeroen Heuts, Eleni Maria Varypataki, Koen van der Maaden et al. · Pharmaceutical Research · 2018 · 57 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells

Arjan Kol, Anton Terwisscha van Scheltinga, Martin Pool et al. · Oncotarget · 2017 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study

Els M.E. Verdegaal, Monique K. van der Kooij, Marten Visser et al. · Journal for ImmunoTherapy of Cancer · 2020 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

1–4 of 4